Literature DB >> 22240157

Association of left ventricular diastolic dysfunction with elevated NT-proBNP in type 2 diabetes mellitus patients with preserved ejection fraction: the supplemantary role of tissue doppler imaging parameters and NT-proBNP levels.

Sedat Çiftel1, Serhat Içağasıoğlu, Gürsel Yıldız, Gonca Tekin, Hüseyin Aydin.   

Abstract

BACKGROUND: Early diagnosis of cardiovascular disease in diabetic patients may be important to introduce treatment early. Echocardiography is a method used to show the ventricular functions. A ventricular hormone, BNP is used to identify the changes in the ventricular function in early period. NT-proBNP which is a more stable compound with a longer half-life is used in measurement of BNP.
METHODS: Left ventricular diastolic dysfunction (LVDD) was detected and NT-proBNP levels were measured in forty-four asymptomatic patients with ages of 30-70 and type 2 DM and control group consisted of 40 healthy individuals from the same age group.
RESULTS: NT-proBNP levels were found as 566.7 ± 738.5 pg/ml in the diabetics with LVDD detected, 166.3 ± 137.1 pg/ml in the diabetics without LVDD and 134.5 ± 77.2 pg/ml in the control group. Levels of NT-proBNP were significantly higher in the group with left ventricular diastolic dysfunction (p<0.05). However, when the levels of NT-proBNP in the diabetic patients without LVDD were compared with the controls, the difference was not significant (p>0.05). NT-proBNP levels were found significantly higher in LVDD group compared to the controls without a difference between the ejection fractions (p<0.05).
CONCLUSION: High levels of NT-proBNP was correlated tissue Doppler echocardiography findings in type 2 DM patients with preserved ejection fraction.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240157     DOI: 10.1016/j.diabres.2011.12.021

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Fasudil improves short-term echocardiographic parameters of diastolic function in patients with type 2 diabetes with preserved left ventricular ejection fraction: a pilot study.

Authors:  Rong Guo; Yang Su; Jing Yan; Hui Sun; Jiakang Wu; Weijing Liu; Yawei Xu
Journal:  Heart Vessels       Date:  2014-01-05       Impact factor: 2.037

Review 2.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

Review 3.  The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

Authors:  Giacomo Zoppini; Corinna Bergamini; Alessandro Mantovani; Marco Dauriz; Giovanni Targher; Andrea Rossi; Enzo Bonora
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

4.  Increased Arterial Stiffness Is Associated With Reduced Diastolic Function in Youth With Obesity and Type 2 Diabetes.

Authors:  Nicolas L Madsen; Jessica E Haley; Ryan A Moore; Philip R Khoury; Elaine M Urbina
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

5.  Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis.

Authors:  Byoung-Geun Han; Jun Young Lee; Mi Ryung Kim; Hanwul Shin; Jae-Seok Kim; Jae-Won Yang; Jong Yeon Kim
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.